Owens & Minor (NYSE:OMI) announced its quarterly earnings data on Wednesday. The company reported $0.10 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.07 by $0.03, Briefing.com reports. The company had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. Owens & Minor had a positive return on equity of 6.92% and a negative net margin of 4.63%. Owens & Minor’s revenue for the quarter was up 1.1% compared to the same quarter last year. During the same period last year, the firm posted $0.32 EPS. Owens & Minor updated its FY 2019 guidance to $0.60-0.70 EPS.
OMI traded up $1.22 on Wednesday, hitting $4.07. 6,438,400 shares of the company were exchanged, compared to its average volume of 1,489,437. The stock’s fifty day moving average price is $2.98. The company has a quick ratio of 0.89, a current ratio of 1.75 and a debt-to-equity ratio of 3.67. Owens & Minor has a 12 month low of $2.43 and a 12 month high of $18.40. The company has a market capitalization of $181.26 million, a PE ratio of 3.54, a PEG ratio of 1.37 and a beta of 1.74.
Institutional investors and hedge funds have recently bought and sold shares of the stock. FMR LLC grew its position in Owens & Minor by 159,300.0% during the 4th quarter. FMR LLC now owns 4,782 shares of the company’s stock worth $30,000 after acquiring an additional 4,779 shares during the last quarter. Atlantic Union Bankshares Corp bought a new position in Owens & Minor during the 2nd quarter worth approximately $36,000. Stone Ridge Asset Management LLC bought a new position in Owens & Minor during the 2nd quarter worth approximately $50,000. First Trust Advisors LP bought a new position in Owens & Minor during the 1st quarter worth approximately $56,000. Finally, First Allied Advisory Services Inc. bought a new position in Owens & Minor during the 4th quarter worth approximately $71,000. Institutional investors and hedge funds own 88.98% of the company’s stock.
OMI has been the topic of a number of research reports. Bank of America reissued a “neutral” rating and set a $4.50 price objective (down from $7.00) on shares of Owens & Minor in a report on Wednesday, April 10th. ValuEngine cut Owens & Minor from a “sell” rating to a “strong sell” rating in a report on Thursday, August 1st. Finally, Zacks Investment Research raised Owens & Minor from a “hold” rating to a “buy” rating and set a $3.25 price objective on the stock in a report on Friday, July 19th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the stock. Owens & Minor has a consensus rating of “Hold” and a consensus target price of $6.13.
About Owens & Minor
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.
Read More: Cash Asset Ratio
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.